“Description of the 3 Tranquillo Phase 3 Clinical Program Study Designs to Assess Ritlecitinib Treatment in Adults and Adolescents With Nonsegmental Vitiligo”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 6, Nov. 2025, p. s714, https://doi.org/10.25251/rm8etw25.